Centaurus Financial Inc. Has $2.13 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Centaurus Financial Inc. lessened its position in Aflac Incorporated (NYSE:AFL) by 1.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 19,055 shares of the financial services provider’s stock after selling 275 shares during the period. Centaurus Financial Inc.’s holdings in Aflac were worth $2,130,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Y.D. More Investments Ltd bought a new stake in Aflac during the 2nd quarter valued at $25,000. Darwin Wealth Management LLC bought a new position in shares of Aflac in the third quarter valued at $34,000. Covestor Ltd grew its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after buying an additional 107 shares during the last quarter. Kennebec Savings Bank bought a new stake in shares of Aflac during the third quarter worth about $45,000. Finally, Catalyst Capital Advisors LLC acquired a new stake in shares of Aflac in the 3rd quarter worth about $51,000. Institutional investors own 67.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. UBS Group lifted their price target on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, August 14th. Morgan Stanley lifted their target price on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. Barclays began coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target for the company. Truist Financial raised their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Finally, Evercore ISI upped their target price on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research note on Thursday, September 26th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $97.93.

Aflac Stock Up 0.6 %

AFL opened at $112.39 on Monday. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The company’s 50-day moving average price is $110.73 and its two-hundred day moving average price is $100.66. The stock has a market cap of $62.44 billion, a price-to-earnings ratio of 16.93, a PEG ratio of 2.15 and a beta of 0.96. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% on a year-over-year basis. As a group, equities analysts expect that Aflac Incorporated will post 7.22 earnings per share for the current year.

Aflac Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. The ex-dividend date is Wednesday, November 20th. This represents a $2.00 annualized dividend and a dividend yield of 1.78%. Aflac’s payout ratio is 30.12%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.